secwatch.observer — SEC 8-K summary
======================================

Issuer:     SOLENO THERAPEUTICS INC (SLNO)
CIK:        0001484565
Form:       8-K
Filed at:   2024-07-19T23:59:59+00:00
Accession:  0001193125-24-181717
Event type: other
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Soleno Therapeutics enters $150M at-the-market equity offering with Jefferies
-----------------------------------------------------------------------------

- Soleno may sell up to $150M of common stock from time to time under Sale Agreement with Jefferies.
- Jefferies will use commercially reasonable efforts to sell shares as an at-the-market offering.
- Commission of 3.0% of gross proceeds; Soleno also reimburses certain expenses.
- Offering made under existing S-3ASR registration statement filed on Jan 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484565/000119312524181717/0001193125-24-181717-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484565/000119312524181717/d817873d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-181717

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer